Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Interest & Investment Income (2018 - 2025)

Neurogene (NGNE) has disclosed Interest & Investment Income for 5 consecutive years, with $2.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest & Investment Income rose 48.75% year-over-year to $2.7 million, compared with a TTM value of $11.1 million through Sep 2025, up 68.06%, and an annual FY2024 reading of $8.5 million, up 186.92% over the prior year.
  • Interest & Investment Income was $2.7 million for Q3 2025 at Neurogene, down from $2.9 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $3.2 million in Q1 2025 and bottomed at $1.8 million in Q3 2024.